Stabilization of hyperforin dicyclohexylammonium salt with dissolved albumin and albumin nanoparticles for studying hyperforin effects on 2D cultivation of keratinocytes in vitro

被引:10
作者
Fueller, J. [1 ,3 ]
Kellner, T. [1 ,3 ]
Gaid, M. [2 ,3 ]
Beerhues, L. [2 ,3 ]
Mueller-Goymann, C. C. [1 ,3 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Technol, Braunschweig, Germany
[2] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Biol, Braunschweig, Germany
[3] Tech Univ Carolo Wilhelmina Braunschweig, Ctr Pharmaceut Engn, Braunschweig, Germany
关键词
Hyperforin; Stabilization; Albumin; Serum; HaCaT; Albumin nanoparticles; ST-JOHNS-WORT; DRUG-DELIVERY; GROWTH;
D O I
10.1016/j.ejpb.2017.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to the limited chemical stability of the natural hyperforin molecule, a more stable form of hyperforin, i.e., the hyperforin dicyclohexylammonium salt (HYP-DCHA) has been used for ex vivo and in vitro experiments in recent years, but its actual stability under typical cell culture conditions has never been studied before. In this contribution the stability of HYP-DCHA was examined under typical cell culture conditions. Different cell culture media with and without fetal calf serum (FCS) supplementation were studied with regard to further stabilization of HYP-DCHA determined with HPLC analysis. Furthermore, albumin nanoparticles were examined as a stabilizing carrier system for HYP-DCHA. In this context, the interaction between HYP-DCHA and albumin nanoparticles (ANP) was examined with regard to size and loading with HYP. The effects of HYP-DCHA either supplied in cell culture medium or loaded on ANP on viability and cytotoxicity were studied in vitro on HaCaT monolayers (human keratinocyte cell line). HYP-DCHA supplied in FCS-containing medium was recovered completely after 24 h of incubation. However, a lack of FCS caused a total loss of HYP-DCHA after less than 24 h incubation time. Supplying HYP-DCHA loaded on ANP in an FCS-free medium resulted in a recovery of about 60% after 24 h incubation. HYP-DCHA supplied in medium along with FCS showed a slow dose -dependent decrease in viability of HaCaT cells without any cytotoxic effects (antiproliferative effect). Treatment with HYP-DCHA with a lack of FCS resulted in a significantly faster decrease in viability which was mainly due to cytotoxicity. The latter was true for HYP-DHCA-loaded ANP where increased cytotoxicity was observed despite the presence of FCS. The results show that the stability of the widely used HYP-DCHA is rather limited under cell culture conditions. Especially a lack of FCS leads to degradation and/or oxidation of HYP-DCHA probably causing an increased cytotoxicity. In contrast, FCS supplementation fairly stabilizes HYP-DCHA under cell culture conditions while albumin nanoparticles may serve the same stabilization purpose despite increasing cytotoxic effects onto the cells themselves.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 24 条
[1]   Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase [J].
Albert, D ;
Zündorf, I ;
Dingermann, T ;
Müller, WE ;
Steinhilber, D ;
Werz, O .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) :1767-1775
[2]  
BENACERRAF B, 1956, C R Seances Soc Biol Fil, V150, P1307
[3]   The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery [J].
Bern, Malin ;
Sand, Kine Marita Knudsen ;
Nilsen, Jeannette ;
Sandlie, Inger ;
Andersen, Jan Terje .
JOURNAL OF CONTROLLED RELEASE, 2015, 211 :144-162
[4]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[5]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[6]  
Chatterjee S.S., 2002, United States Patent, Patent No. [6,444,662 B1, 6444662]
[7]   Lipid nanocapsules containing the non-ionic surfactant Solutol HS15 inhibit the transport of calcium through hyperforin-activated channels in neuronal cells [J].
Chauvet, Sylvain ;
Barras, Alexandre ;
Boukherroub, Rabah ;
Bouron, Alexandre .
NEUROPHARMACOLOGY, 2015, 99 :726-734
[8]   Hyperforin inhibits cancer invasion and metastasis [J].
Donà, M ;
Dell'Aica, I ;
Pezzato, E ;
Sartor, L ;
Calabrese, F ;
Della Barbera, M ;
Donella-Deana, A ;
Appendino, G ;
Borsarini, A ;
Caniato, R ;
Garbisa, S .
CANCER RESEARCH, 2004, 64 (17) :6225-6232
[9]   Impact of albumin on drug delivery - New applications on the horizon [J].
Elsadek, Bakheet ;
Kratz, Felix .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (01) :4-28
[10]   Albumin-based nanoparticles as potential controlled release drug delivery systems [J].
Elzoghby, Ahmed O. ;
Samy, Wael M. ;
Elgindy, Nazik A. .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (02) :168-182